Assessing the effectiveness of whole blood-derived platelets stored as a pool: A randomized block noninferiority trial

Transfusion

Volumn 45, Issue 6, 2005, Pages 896-903

  Heddle, Nancy M ^a   Cook, R J ^b   Blajchman, M A ^b   Barty, R L ^b   Sigouin, C S ^b   Boye, D M ^b   Nelson, E J ^b   Kelton, J G ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD STORAGE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ADULT; AGED; BLOOD PLATELETS; BLOOD PRESERVATION; HUMANS; MIDDLE AGED; PLATELET COUNT; PLATELET TRANSFUSION; THROMBOCYTOPENIA; TIME FACTORS;

EID: 20444418075     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2005.04233.x     Document Type: Article

References (24)

1. Components from whole blood donations. In: AABB Technical Manual. 14th ed. Bethesda: American Association of Blood Banks; 2002. p. 180.
2. Snyder EL, Stack G, Napychank P, et al. Storage of pooled platelet concentrates: in vitro and in vivo analysis. Transfusion 1989;29:390-5.
3. Moroff G, Holme S, Dabay MH, et al. Storage of pools of six and eight platelet concentrates. Transfusion 1993;33:374-8.
4. Wagner SJ, Moroff G, Katz AJ, et al. Comparison of bacteria growth in single and pooled platelet concentrates after deliberate inoculation and storage. Transfusion 1995;35:298-302.
5. AABB standards for blood banks and transfusion services. 22nd ed. Bethesda: American Association of Blood Banks; 2003. p. 12-3.
6. Margolis-Nunno H, Williams B, Rywkin S, et al. Virus sterilization in platelet concentrates with psoralen and ultraviolet A light in the presence of quenchers. Transfusion 1992;32:541-7.
7. Lin L, Londe H, Janda JM, et al. Photochemical inactivation of pathogenic bacteria in human platelet concentrates. Blood 1994;83:2698-706.
8. Margolis-Nunno H, Robinson R, Ben Hur E, et al. Elimination of potential mutagenicity in platelet concentrates that are virally inactivated with psoralens and ultraviolet A light. Transfusion 1995;35:855-62.
9. Heddle NM, Barty R, Sigouin C, et al. Prestorage leukoreduced whole blood-derived platelets stored as a pool for up to seven days. Transfusion 2005;45:in press.
10. Sweeney JD, Kouttab NM, Holme S, et al. Prestorage pooled whole-blood-derived leukoreduced platelets stored for seven days, preserve acceptable quality and do not show evidence of a mixed lymphocyte reaction. Transfusion 2004;44:1212-9.
11. Methods: blood collection, storage, and component preparation. In: AABB technical manual. 14th ed. Bethesda: American Association of Blood Banks; 2002. p. 748-9.
12. Platelet and granulocyte antigens and antibodies. In: AABB technical manual. 13th ed. Bethesda: American Association of Blood Banks; 1999. p. 347.
13. Tang ML, Tang NS, Chan IS, et al. Sample size determination for establishing equivalence/noninferiority via ratio of two proportions in matched-pair design. Biometrics 2002;58:957-63.
14. Heddle NM, Klama L, Meyer R, et al. A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets. Transfusion 1999;39:231-8.
15. Heddle NM, Blajchman MA, Meyer RM, et al. A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets. Transfusion 2002;42:556-66.
16. Tang NS, Tang ML, Chan IS. On tests of equivalence via nonunity relative risk for matched-pair design. Stat Med 2003;22:1217-33.
17. Carey V, Zeger SL, Diggle PJ. Modelling multivariate binary data with alternating logistic regressions. Biometrika 1993;80:517-26.
18. Kickler TS. The platelet transfusion refractory state. In: Transfusion practices and clinical management in clinical decusion in platelet therapy. Bethesda: American Association of Blood Banks; 1992.
19. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer 1981;47:207-14.
20. Bishop JF, Matthews JP, McGrath K, et al. Factors influencing 20-hour increments after platelet transfusion. Transfusion 1991;31:392-6.
21. McFarland JG, Anderson AJ, Slichter SJ. Factors influencing the transfusion response to HLA-selected apheresis donor platelets in patients refractory to random platelet concentrates. Br J Haematol 1989;73:380-6.
22. Blajchman MA, Ali A, Lyn P, et al. A prospective study to determine the frequency of bacterial contamination in random donor platelet concentrates [abstract]. Blood 1994;84:529.
23. Blajchman MA, Ali A, Lyn P, et al. Bacterial surveillance of platelet concentrates: quantitation of bacterial load [abstract]. Transfusion 1997;37:74S.
24. Heddle NM, Cook RJ, Webert KE, et al. Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies. Transfusion 2003;43:742-52.